Drug Type Enzyme |
Synonyms GF 103, GF103 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Wet age-related macular degeneration | Phase 1 | South Korea | - | |
| Diabetic macular oedema | Preclinical | South Korea | 01 Sep 2026 | |
| Mucositis | Preclinical | South Korea | 01 Sep 2026 | |
| Inflammatory Bowel Diseases | Preclinical | South Korea | 22 Aug 2024 | |
| Wet Macular Degeneration | Preclinical | South Korea | 22 Aug 2024 |






